Skip to main content

Table 1 Endocrinological characteristics of ACC and CPA

From: Steroid metabolites for diagnosing and predicting clinicopathological features in cortisol-producing adrenocortical carcinoma

Variable

Unit

ACC (n = 7)

CPA (n = 25)

P-value

Overt Cushing’s syndrome

Subclinical Cushing’s syndrome

Overt Cushing’s syndrome

Subclinical Cushing’s syndrome

 

Number of patients

n (%)

4 (57%)

3 (43%)

11 (44%)

14 (56%)

NS

Basal ACTH levels

pg/ml

2.6 (0–5.97)

5.5 (2.75–11.6)

0 (0–0)

10.05 (1.67–13.67)

 

Basal cortisol levels

ÎĽg/ml

22.45 (12.7–33.4)

8 (5.9–10.65)

17.6 (15.6–18.35)

11.15 (9.8–13.87)

 

High testosterone levels relative to normal ranges

n (%)

3 (43%)

2 (8%)

< 0.05

Basal testosterone levels

ng/ml

Male: 2.29 (1.27–3.30)

Female: 1.3 (0.36–1.97)

Male: 5.61 (4.42–6.64)

Female: 0.19 (0.15–0.26)

 

Age

years

67 (66–71.5)

56 (45–63)

< 0.05

Gender

Male/ Female

2 / 5

4 / 21

NS

Post-overnight 1 mg dexamethasone suppression serum cortisol

ÎĽg/dl

16.4 (10.65–21.15)

10.3 (3.87–15.8)

NS

Post-overnight 8 mg dexamethasone suppression serum cortisol

ÎĽg/dl

16.2 (10.6–21.55)

12.05 (4.75–18.03)

NS

Urinary free cortisol

ÎĽg/day

128.15 (59.63–148)

71.5 (29.7–267)

NS

Tumor size

mm

80.5 (61.25–82.5)

28 (22–33)

< 0.01

Surgical removal of adrenal tumor

n (%)

7 (100%)

20 (80%)

NS

Weiss score

 

5.5 (5–6.75)

0 (0–1)

< 0.001

Ki67-index

%

23 (20.75–28.25)

 

ENSAT

stage

3 (2–4)

 

Overall survival

months

25 (17–50)

 
  1. Data were expressed as median (interquartile ranges). P < 0.05 was defined as significant. NS nonsignificant, ACC adrenocortical carcinomas, CPA cortisol-producing adenomas